Influence of site differences between urban and rural American and central European opioid-dependent pregnant women and neonatal outcome characteristics

European Addiction Research

Volumn 18, Issue 3, 2012, Pages 130-139

  Baewert, Andjela ^a   Jagsch, Reinhold ^b   Winklbaur, Bernadette ^a   Kaiser, Gerda ^a   Thau, Kenneth ^a   Unger, Annemarie ^a   Aschauer, Constantin ^a   Weninger, Manfred ^a   Metz, Verena ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Buprenorphine; Maternal and neonatal outcome; Methadone; Opioid dependence; Pregnancy; Regional disparities

Indexed keywords

BUPRENORPHINE; METHADONE;

ADULT; ARTICLE; AUSTRIA; CESAREAN SECTION; COCAINE DEPENDENCE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; ETHNIC DIFFERENCE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OPIATE ADDICTION; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; RURAL AREA; TREATMENT DURATION; UNITED STATES; URBAN AREA; URBAN RURAL DIFFERENCE;

ADOLESCENT; ADULT; BUPRENORPHINE; DOUBLE-BLIND METHOD; EUROPE; FEMALE; HUMANS; INFANT, NEWBORN; METHADONE; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANT WOMEN; PROSPECTIVE STUDIES; RURAL POPULATION; UNITED STATES; URBAN POPULATION; YOUNG ADULT;

EID: 84857131449     PISSN: 10226877     EISSN: 14219891     Source Type: Journal    
DOI: 10.1159/000335082     Document Type: Article

References (44)

1. UNODC: World Drug Report 2010. United Nations, New York, 2010. Available at http://www.unodc.org/documents/wdr/WDR-2010/World-Drug-Report-2010-lo-res.pdf (accessed 28.9.2011).
2. Behnke M, Eyler FD, Conlon M, Casanova OQ, Woods NS: How fetal cocaine exposure increases neonatal hospital costs. Pediatrics 1997; 99: 204-208. (Pubitemid 27148871)
3. Derauf C, Kekatpure M, Neyzi N, Lester B, Kosofsky B: Neuroimaging of children following prenatal drug exposure. Semin Cell Dev Biol 2009; 20: 441-454.
4. Cavanaugh CE, Latimer WW: Recent sex trade and injection drug use among pregnant opiate-and cocaine-dependent women in treatment: The significance of psychiatric comorbidity. Addict Disord Their Treat 2010; 9: 32-40.
5. Fischer G: Treatment of opioid dependence in pregnant women. Addiction 2000; 95: 1141-1144. (Pubitemid 30644100)
6. Winklbaur B, Baewert A, Jagsch R, Rohrmeister K, Metz V, Aeschbach Jachmann C, Thau K, Fischer G: Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. Implications for treatment. Eur Addict Res 2009; 15: 150-156.
7. Lauder W, Roxburgh M, Harris J, Law J: Developing self-neglect theory: Analysis of related and atypical cases of people identified as self-neglecting. J Psychiatr Ment Health Nurs 2009; 16: 447-454.
8. Grella CE, Karno MP, Warda US, Niv N, Moore AA: Gender and comorbidity among individuals with opioid use disorders in the NESARC study. Addict Behav 2009; 34: 498-504.
9. Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR, Fischer G: Neonatal abstinence syndrome following methadone or buprenorphine exposure. N Engl J Med 2010; 363: 2320-2331.
10. Winklbaur B, Kopf N, Ebner N, Jung E, Thau K, Fischer G: Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: A knowledge synthesis for better treatment for women and neonates. Addiction 2008; 103: 1429-1440.
11. Fiellin DA, Kleber H, Trumble-Hejduk JG, McLellan AT, Kosten TR: Consensus statement on office-based treatment of opioid dependence using buprenorphine. J Subst Abuse Treat 2004; 27: 153-159. (Pubitemid 39265427)
12. Unger A, Jung E, Winklbaur B, Fischer G: Gender issues in the pharmacotherapy of opioid-addicted women: Buprenorphine. J Addict Dis 2010; 29: 217-230.
13. Jones HE, Johnson RE, Jasinski DR, O'Grady KE, Chisholm CA, Choo RE, Crocetti M, Dudas R, Harrow C, Huestis MA, Jansson LM, Lantz M, Lester BM, Milio L: Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: Effects on the neonatal abstinence syndrome. Drug Alcohol Depend 2005; 79: 1-10. (Pubitemid 41557119)
14. Fischer G, Ortner R, Rohrmeister K, Jagsch R, Baewert A, Langer M, Aschauer H: Methadone versus buprenorphine in pregnant addicts: A double-blind, double-dummy comparison study. Addiction 2006; 101: 275-281. (Pubitemid 43351601)
15. Stine SM, Heil SH, Kaltenbach K, Martin PR, Coyle MG, Fischer G, Arria AM, Selby P, Jones HE: Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: Screening results from the MOTHER study. Am J Drug Alcohol Abuse 2009; 35: 429-433.
16. Jones HE, Martin PR, Heil SH, Kaltenbach K, Selby P, Coyle MG, Stine SM, O'Grady KE, Arria AM, Fischer G: Treatment of opioiddependent pregnant women: Clinical and research issues. J Subst Abuse Treat 2008; 35: 245-259.
17. Unger AS, Martin PR, Kaltenbach K, Stine SM, Heil SH, Jones HE, Arria AM, Coyle MG, Selby P, Fischer G: Clinical characteristics of Central European and North American samples of pregnant women screened for opioid agonist treatment. Eur Addict Res 2010; 16: 99-107.
18. Finnegan LP, Connaughton JF Jr., Kron RE, Emich JP: Neonatal Abstinence Syndrome: Assessment and management. Addict Dis 1975; 2: 141-158.
19. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M: The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9: 199-213.
20. Martino SC, Ellickson PL, McCaffrey DF: Developmental trajectories of substance use from early to late adolescence: A comparison of rural and urban youth. J Stud Alcohol Drugs 2008; 69: 430-440.
21. Metsch LR, McCoy CB: Drug treatment experiences: Rural and urban comparisons. Subst Use Misuse 1999; 34: 763-784. (Pubitemid 29156097)
22. Heil SH, Sigmon SC, Jones HE, Wagner M: Comparison of characteristics of opioid-using pregnant women in rural and urban settings. Am J Drug Alcohol Abuse 2008; 34: 463-471. (Pubitemid 351913749)
23. Bäwert A, Primus N, Jagsch R, Eder H, Zanki M, Thau K, Fischer G: Cocaine abuse in Vienna and European cities -a multi-centre study. Wien Klin Wochenschr 2006; 118: 521-530. (Pubitemid 44579744)
24. Dunn MS, Ilapogu V, Taylor L, Naney C, Blackwell R, Wilder R, Givens C: Self-reported substance use and sexual behaviors among adolescents in a rural state. J Sch Health 2008; 78: 587-593.
25. Rostosky SS, Owens GP, Zimmermann RS, Riggle ED: Associations among sexual attraction status, school belonging, and alcohol and marijuana use in rural high school students. J Adolesc 2003; 26: 741-751. (Pubitemid 37536711)
26. Morgenstern J, Blanchard KA, Kahler C, Barbosa KM, McCrady BS, McVeigh KH: Testing mechanisms of action for intensive case management. Addiction 2008; 103: 469-477. (Pubitemid 351208107)
27. Brooner RK, Kidorf MS, Stoller KB, Neufeld KJ, Kolodner K: Comparing adaptive stepped care and monetary-based voucher intervention for opioid dependence. Drug Alcohol Depend 2007; 88(suppl 2):14-23.
28. Henderson M, Wight D, Nixon C, Hart G: Retaining young people in a longitudinal sexual health survey: A trial of strategies to maintain participation. BMC Med Res Methodol 2010; 10: 9.
29. Meyers K, Webb A, Frantz J, Randall M: What does it take to retain substance-abusing adolescents in research protocols? Delineation of effort required, strategies undertaken, costs incurred, and 6-month posttreatment differences by retention difficulty. Drug Alcohol Depend 2003; 69: 73-85. (Pubitemid 36110463)
30. Kelly SM, O'Grady KE, Brown BS, Mitchell SG, Schwartz RP: The role of patient satisfaction in methadone treatment. Am J Drug Alcohol Abuse 2010; 36: 150-154.
31. Colombini N, Elias R, Busuttil M, Dubuc M, Einaudi MA, Bues-Charbit M: Hospital morphine preparation for abstinence syndrome in newborns exposed to buprenorphine or methadone. Pharm World Sci 2008; 30: 227-234.
32. Binder T, Vavrinková B: Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birth weight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome in women followed up in the outpatient department. Neuro Endocrinol Lett 2008; 29: 80-86.
33. Eder H, Fischer G, Gombas W, Jagsch R, Stühlinger G, Kasper S: Comparison of buprenorphine and methadone maintenance in opiate addicts. Eur Addict Res 1998; 4 (suppl 1):3-7. (Pubitemid 28478987)
34. Fischer G, Johnson RE, Eder H, Jagsch R, Peternell A, Weninger M, Langer M, Aschauer HN: Treatment of opioid-dependent pregnant women with buprenorphine. Addiction 2000; 95: 239-244. (Pubitemid 30111244)
35. Schindler SD, Eder H, Ortner R, Rohrmeister K, Langer M, Fischer G: Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction 2003; 98: 103-110. (Pubitemid 36044342)
36. Ortner R, Jagsch R, Schindler SD, Primorac A, Fischer G, General Practitioner Addiction Team. Buprenorphine maintenance: Officebased treatment with addiction clinic support. Eur Addict Res 2004; 10: 105-111. (Pubitemid 39070098)
37. Fischer G, Ortner R, Rohrmeister K, Jagsch R, Baewert A, Langer M, Aschauer H: Methadone versus buprenorphine in pregnant addicts: A double-blind, double-dummy comparison study. Addiction 2006; 101: 275-281. (Pubitemid 43351601)
38. Unger A, Jagsch R, Jones H, Arria A, Leitich H, Rohrmeister K, Aschauer C, Winklbaur B, Bäwert A, Fischer G: Randomized controlled trials in pregnancy: Scientific and ethical aspects exposure to different opioid medications during pregnancy in an intraindividual comparison. Addiction 2011; 106: 1355-1362.
39. Fride E: The endocannabinoid-CB(1) receptor system in pre-and postnatal life. Eur J Pharmacol 2004; 500: 289-297. (Pubitemid 39304016)
40. Stone KC, LaGasse LL, Lester BM, Shankaran S, Bada HS, Bauer CR, Hammond JA: Sleep problems in children with prenatal substance exposure: The Maternal Lifestyle study. Arch Pediatr Adolesc Med 2010; 164: 452-456.
41. Wilkin D: Restructuring primary and community health services in four countries: From cottage industry to integrated provider? Health Soc Care Community 2002; 10: 309-312. (Pubitemid 36844244)
42. Wilensky HL: Social science and the public agenda: Reflections on the relation of knowledge to policy in the United States and abroad. J Health Polit Policy Law 1997; 22: 1241-1265. (Pubitemid 27495375)
43. Aeschbach Jachmann C, Jagsch R, Winklbaur B, Matzenauer C, Fischer G: Officebased treatment in opioid dependence: A critical survey of prescription practices for opioid maintenance medications and concomitant benzodiazepines in Vienna, Austria. Eur Addict Res 2008; 14: 206-212.
44. Keen J, Oliver P, Rowse G, Mathers N: Does methadone maintenance treatment based on the new national guidelines work in a primary care setting? Br J Gen Pract 2003; 53: 461-467. (Pubitemid 36740612)